Overview
Title
An Act To amend the Public Health Service Act to reauthorize a national congenital heart disease research, surveillance, and awareness program, and for other purposes.
ELI5 AI
H.R. 7189 wants to help kids and people with heart problems they were born with by continuing to study and teach people about it. The bill says the health department has to plan better ways to do this and keep track of progress for a few more years.
Summary AI
H.R. 7189, known as the "Congenital Heart Futures Reauthorization Act of 2024," aims to amend the Public Health Service Act to renew support for research, awareness, and monitoring programs related to congenital heart disease. The bill requires the Department of Health and Human Services to submit a report about efforts to raise public awareness and education on congenital heart disease and to develop a strategy to improve these areas. The plan should also address gaps and opportunities in public awareness, research, and provider workforce shortages. This reauthorization extends the program from 2025 through 2029.
Published
Keywords AI
Sources
Bill Statistics
Size
Language
Complexity
AnalysisAI
Summary of the Bill
H.R. 7189, also known as the "Congenital Heart Futures Reauthorization Act of 2024," is legislation intended to amend the Public Health Service Act. The bill focuses on continuing and enhancing the national program for research, surveillance, and awareness of congenital heart disease. It mandates the creation of a detailed report and strategy for boosting public awareness and the training of healthcare providers regarding congenital heart disease. The bill also extends the funding timeline for this program through 2029, providing a structured framework for the next several years.
Significant Issues
Several key issues emerge from the provisions of this bill:
Timeliness of Report and Strategy: Section 2 of the bill demands a report and strategy to be submitted within a specified timeframe. Concerns arise regarding whether the Department of Health and Human Services will have the necessary resources and data to meet these deadlines effectively.
Stakeholder Consultation: The requirement for consultation with a broad array of stakeholders, such as patient organizations and health professionals, is a key aspect of strategy development. Ensuring comprehensive representation and inclusivity poses ethical and logistical challenges.
Administrative and Legal Adjustments: The redesignation of subsections and amendments regarding funding duration may lead to administrative changes. Entities dependent on these funds might face legal and financial challenges adapting to the new structure.
Impact on the Public
Broadly, the bill aims to enhance awareness and understanding of congenital heart disease, benefiting patients and the general public by potentially improving healthcare outcomes. By pushing for educational initiatives and workforce assessments, the bill seeks to ensure more informed healthcare delivery, which could lead to better long-term health management for those affected by congenital heart disease.
Impact on Specific Stakeholders
Healthcare Providers: The requirement for better training and education could lead to an improved standard of care for congenital heart disease patients. However, securing resources for such educational initiatives could burden some healthcare systems.
Patient Organizations: Being involved in the strategy development process empowers these organizations by having their concerns and insights directly influence national health policy. Nevertheless, ensuring that all relevant voices are heard might be complex and resource-intensive.
Federal and State Health Agencies: These agencies may experience an increased administrative load to meet the expectations set out by the bill. Ensuring effective collaboration and data sharing among diverse stakeholders will be critical to achieving the bill’s objectives.
In conclusion, while H.R. 7189 presents an opportunity to deepen the nation’s approach to congenital heart disease, it also introduces challenges related to resource allocation, stakeholder engagement, and compliance with new administrative structures. The bill’s success will substantially depend on strategic implementation and effective cooperation among all involved parties.
Issues
The requirement for the Secretary to submit a report and strategy within a specific timeline could raise feasibility concerns regarding the availability of resources and data to meet these deadlines. This is significant to the general public and policymakers who are invested in the timeliness and efficacy of health initiatives. (Section 2)
The bill requires consultations with a diverse group of stakeholders, including patient organizations, which could raise ethical and logistical challenges in ensuring that all relevant voices are heard and adequately represented in the strategy development. This is important for ensuring ethical inclusivity and holistic stakeholder engagement. (Section 2)
The redesignation of subsections and the amendment of funding duration could have administrative implications, affecting how entities comply with the new legal structure and funding timelines. This may have legal and financial significance, particularly for organizations relying on these funds. (Section 2)
Sections
Sections are presented as they are annotated in the original legislative text. Any missing headers, numbers, or non-consecutive order is due to the original text.
1. Short title Read Opens in new tab
Summary AI
The first section of the bill specifies that it can be referred to as the “Congenital Heart Futures Reauthorization Act of 2024.”
2. Reauthorization of national congenital heart disease research, surveillance, and awareness program Read Opens in new tab
Summary AI
The section amends a part of the Public Health Service Act to require a report and strategy focused on congenital heart disease. It calls for increased public awareness and education for healthcare providers, assesses workforce capacity, and extends funding for the program through 2029.